BSF Enterprise completes acquisition of 3D Bio-Tissues Limited

17th May 2022

BSF Enterprise (LSE: BSFA) has today announced the completion of the reverse takeover of  3D Bio-Tissues Limited, a tissue engineering business based in Newcastle.  Admission of the enlarged group to the standard segment of the Official List commenced this morning.

3D Bio-Tissues Limited is already producing human corneas that could help restore vision to millions of people and is also focused on producing the UK’s first 100% lab-grown meat in the next 12 months. The cultured meat sector is forecast to have a CAGR rate of over 400% from 2021-2030 and an estimated market size of almost $13bn by 2030.

Below is an interview with BSF Directors Dr Che Connon and Geoff Baker who highlight the rationale behind the acquisition and the opportunity open to the enlarged business